A “Twist” In Making DNA Means Huge Growth Prospects For This Stock

The synthetic biology company discussed in today’s article is a favorite of ARK Invest CEO Cathie Wood. In fact, it’s the fifth-largest holding in her ARK Genomic Revolution ETF. Why does Wood like this stock so much? The contributors discuss the critical “twist” in how the company makes DNA – and how its growth prospects remind them of another pioneer in the genomic revolution. For more, CLICK HERE.